MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10147-020-01665-2

Медицинская библиотека · International journal of clinical oncology · 2020

A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).

Nishimura Yasumasa, Ishikura Satoshi, Shibata Taro, Kodaira Takeshi, Ito Yoshinori, Tsuchiya Kazuhiko, Murakami Yuji, Saitoh Jun-Ichi, Akimoto Tetsuo, Nakata Kensei, Yoshimura Michio, Teshima Teruki, Toshiyasu Takashi, Ota Yosuke, Ishikawa Kazuki, Shimizu Hidetoshi, Minemura Toshiyuki, Nakamura Kenichi, Hiraoka Masahiro

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

A phase II study of adaptive two-step intensity-modulated radiotherapy (IMRT) with chemotherapy for nasopharyngeal cancer (NPC) (JCOG1015) was conducted to evaluate the efficacy and safety.

METHODS

Patients aged 20-75 years with stages II-IVB NPC were enrolled. As adaptive two-step IMRT, computed tomography planning was performed twice before IMRT for the initial plan of 46 Gy/23 fractions and during treatment for the boost plan of 24 Gy/12 fractions with a total dose of 70 Gy. Chemotherapy (cisplatin 80 mg/m2/3-weeks × 3 courses) was administered concurrently with IMRT, followed by adjuvant chemotherapy (cisplatin at 70 mg/m2 with 5-FU 700 at mg/m2 for 5 days/4 weeks × 3 courses).

RESULTS

Between 2011 and 2014, 75 patients were enrolled from 12 institutions. The 3-year overall survival (OS) for the 75 patients was 88%, and the upper and lower limits of the 95% CI of 78%-94% were higher than the expected 3-year OS of 75% for the target population adjusted by the actual proportion of stage II:III:IV = 21%:44%:35%. The 3-year progression-free survival (PFS) and loco-regional PFS were 71% [59-80%] and 77% [66-85%], respectively. Although no grade 4-5 late toxicities were observed, 15 patients (20%) developed grade 3 late toxicities. Grade 2 xerostomia was noted in 26%, 12%, and 9% at 1, 2, and 3 years after starting IMRT, respectively.

CONCLUSIONS

Adaptive two-step IMRT for NPC demonstrated an excellent 3-year OS with acceptable toxicities. This method may be one treatment option for locally advanced NPC.

Для цитирования: Nishimura Yasumasa, Ishikura Satoshi, Shibata Taro, Kodaira Takeshi, Ito Yoshinori, Tsuchiya Kazuhiko, Murakami Yuji, Saitoh Jun-Ichi, Akimoto Tetsuo, Nakata Kensei, Yoshimura Michio, Teshima Teruki, Toshiyasu Takashi, Ota Yosuke, Ishikawa Kazuki, Shimizu Hidetoshi, Minemura Toshiyuki, Nakamura Kenichi, Hiraoka Masahiro. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).. International journal of clinical oncology. 2020. DOI: 10.1007/s10147-020-01665-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.